Correlation Between Pharmala Biotech and XOMA

Can any of the company-specific risk be diversified away by investing in both Pharmala Biotech and XOMA at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Pharmala Biotech and XOMA into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Pharmala Biotech Holdings and XOMA Corporation, you can compare the effects of market volatilities on Pharmala Biotech and XOMA and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pharmala Biotech with a short position of XOMA. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pharmala Biotech and XOMA.

Diversification Opportunities for Pharmala Biotech and XOMA

0.0

Correlation Coefficient

Pharmala Biotech  XOMA

Pay attention - limited upside

The 3 months correlation between Pharmala and XOMA is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Pharmala Biotech Holdings and XOMA Corp. in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on XOMA and Pharmala Biotech is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pharmala Biotech Holdings are associated (or correlated) with XOMA. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of XOMA has no effect on the direction of Pharmala Biotech i.e., Pharmala Biotech and XOMA go up and down completely randomly.

Pair Corralation between Pharmala Biotech and XOMA

If you would invest  2,134  in XOMA Corporation on December 5, 2024 and sell it today you would earn a total of  406.00  from holding XOMA Corporation or generate 19.03% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Flat
Strength	Insignificant
Accuracy	0.0%
Values	Daily Returns

Pharmala Biotech Holdings  vs.  XOMA Corp.

Pharmala Biotech Holdings

Risk-Adjusted Performance

Very Weak

Over the last 90 days Pharmala Biotech Holdings has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly stable technical indicators, Pharmala Biotech is not utilizing all of its potentials. The current stock price disturbance, may contribute to mid-run losses for the stockholders.

XOMA

Risk-Adjusted Performance

OK

Compared to the overall equity markets, risk-adjusted returns on investments in XOMA Corporation are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. In spite of very healthy basic indicators, XOMA is not utilizing all of its potentials. The latest stock price disarray, may contribute to short-term losses for the investors.

Pair Trading with Pharmala Biotech and XOMA

The main advantage of trading using opposite Pharmala Biotech and XOMA positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pharmala Biotech position performs unexpectedly, XOMA can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in XOMA will offset losses from the drop in XOMA's long position.

The idea behind Pharmala Biotech Holdings and XOMA Corporation pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.